NL-OMON24944已完成不适用
RAAS-blockade in type II diabetes: added effects of low sodium diet and diuretics.
niversity Medical Center Groningen (UMCG)0 个研究点目标入组 55 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 55
研究概览
简要总结
Effects of sodium restriction and hydrochlorothiazide on RAAS blockade efficacy in diabetic nephropathy: a randomised clinical trial.
Kwakernaak AJ, Krikken JA, Binnenmars SH, Visser FW, Hemmelder MH, Woittiez AJ, Groen H, Laverman GD, Navis G; Holland Nephrology Study (HONEST) Group.
Lancet Diabetes Endocrinol. 2014 May;2(5):385-95. doi: 10.1016/S2213-8587(14)70030-0. Epub 2014 Mar 5.
PMID nummer van de plublicatie is: 24795252
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. Diabetic nephropathy;
- •2. Diabetes mellitus type II;
排除标准
- •1. Diabetes mellitus type I;
- •2. Myocardial infarction or other cardiovascular or cerebrovascular event within the last 3 months prior to entry into the study;
研究者
相似试验
已完成
不适用
RAAS-blockade in type II diabetes: added effects of a low sodium diet and diuretics.diabetesNL-OMON35646niversitair Medisch Centrum Groningen55
招募中
不适用
Azilsartan in Patients With Diabetic Kidney Disease and HypertensionProteinuriaKidney DysfunctionBlood PressureDiabetic Kidney DiseaseNCT05753696Second Affiliated Hospital, School of Medicine, Zhejiang University106
已完成
不适用
Renin Angiotensin SyStem blockade: diabetes nephropathyISRCTN65752530Canadian Institutes of Health Research (CIHR) (Canada)223
已完成
3 期
DETAIL Study: Diabetes Exposed to Telmisartan and EnalaprilHypertensionDiabetes Mellitus, Type 2NCT00274118Boehringer Ingelheim250
已完成
不适用
Renal protective effect after administration of sodium-glucose cotransporter 2 inhibitors in type 2 diabetes patients and chronic kidney disease with normoalbuminuriatype 2 diabetesJPRN-UMIN000040424Obihiro-Kosei General Hospital46